Skip to main content
. 2014 May 7;5(11):3526–3540. doi: 10.18632/oncotarget.1954

Figure 5. Acrolein treatment inhibits nucleotide excision repair and base excision repair in human urothelial cells.

Figure 5

Immortalized human urothelial (UROtsa) cells were treated with 0, 10, 20, or 50 μM acrolein for 1 h at 37 °C. The nucleotide excision and base excision repair capacity in these cells were determined by (A) an in vitro DNA damage dependent repair synthesis assay using UV-irradiated or H2O2 modified pUC18 plasmid DNA as substrates, and (B) a host cell reactivation assay using UV-irradiated or H2O2 modified luciferase plasmid pGL3 as substrates, as previously described (13, 26).